Literature DB >> 26618050

Relationship between CYP17A1 Genetic Polymorphism and Essential Hypertension in a Chinese Population.

Chuan-Fang Dai1, Xiang Xie1, Yi-Tong Ma1, Yi-Ning Yang1, Xiao-Mei Li1, Zhen-Yan Fu1, Fen Liu1, Bang-Dang Chen1, Min-Tao Gai1.   

Abstract

The relationship between CYP17A1 genetic polymorphisms and essential hypertension (EH) remains unclear. The aim of this study was to investigate the association of CYP17A1 genetic polymorphisms with EH in Han and Uighur populations in China. A Han population including 558 people (270 EH patients and 288 controls) and a Uighur population including 473 people (181 EH patients and 292 controls) were selected. Five single-nucleotide polymorphisms (SNPs) (rs4919686, rs1004467, rs4919687, rs10786712, and rs2486758) were genotyped using real-time PCR (TaqMan). In the Uighur population, for the total and the men, rs4919686, rs4919687 and rs10786712 were found to be associated with EH (rs4919686: P≤0.02, rs4919687: P≤0.002, rs10786712: P≤0.004, respectively). The difference remained statistically significant after the multivariate adjustment (all P<0.05). The overall distributions of the haplotypes established by SNP1-SNP3, SNP1-SNP4, SNP1-SNP3-SNP5 and SNP1-SNP4-SNP5 were significantly different between the EH patients and the control subjects (for the total: P=0.013, P=0.008, P=0.032, P=0.010, for men: P<0.001, P=0.001, P=0.010, P=0.00). In the Han population, for men, rs2486758 was found to be associated with EH in a recessive model (P=0.007); the significant difference was not retained after the adjustment for the covariates (date not shown). The A allele of rs4919686 could be a susceptible genetic marker, and the T allele of rs10786712 could be a protective genetic marker of EH. The AC genotype of rs4919686, the AG genotype of rs4919687 and the TT genotype of rs10786712 could be protective genetic markers of EH.

Entities:  

Keywords:  CYP17A1 gene; case-control study; essential hypertension; single nucleotide polymorphism

Year:  2015        PMID: 26618050      PMCID: PMC4657820          DOI: 10.14336/AD.2015.0505

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  35 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

3.  Human prostacyclin synthase gene and hypertension : the Suita Study.

Authors:  N Iwai; T Katsuya; K Ishikawa; T Mannami; J Ogata; J Higaki; T Ogihara; T Tanabe; S Baba
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

Review 4.  Hypertension and kidney disease: a deadly connection.

Authors:  Yousri M Barri
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

5.  Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.

Authors:  Lorraine M King; James V Gainer; Gloria L David; Ding Dai; Joyce A Goldstein; Nancy J Brown; Darryl C Zeldin
Journal:  Pharmacogenet Genomics       Date:  2005-01       Impact factor: 2.089

6.  Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in She ethnic minority of China.

Authors:  Yinghua Lin; Xiaolan Lai; Bin Chen; Yuan Xu; Baoying Huang; Zichun Chen; Shaoheng Zhu; Jin Yao; Qiqin Jiang; Huibin Huang; Junping Wen; Gang Chen
Journal:  Atherosclerosis       Date:  2011-09-16       Impact factor: 5.162

7.  Hepatic lipase gene variation is related to coronary reactivity in healthy young men.

Authors:  Y Fan; R Laaksonen; T Janatuinen; R Vesalainen; P Nuutila; T Koivula; J Knuuti; T Lehtimäki
Journal:  Eur J Clin Invest       Date:  2001-07       Impact factor: 4.686

Review 8.  [Serum testosterone and cardiovascular disease in men].

Authors:  Emmanuela Quental Callou de Sá; Francisco Carleial Feijó de Sá; Alexis Dourado Guedes; Ieda Therezinha do Nascimento Verreschi
Journal:  Arq Bras Endocrinol Metabol       Date:  2009-11

Review 9.  Genetics of human hypertension.

Authors:  Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2003-12       Impact factor: 1.443

10.  Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: An 8-year prospective study.

Authors:  Sven E Nilsson; Eleonor Fransson; Kerstin Brismar
Journal:  Gend Med       Date:  2009-09
View more
  4 in total

1.  Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25(OH) D levels in Han Chinese.

Authors:  Ning Zhang; Jian Jia; Qiuju Ding; Huimei Chen; Xiaoman Ye; Haixia Ding; Yiyang Zhan
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

2.  Association of CYP17A1 Genetic Polymorphisms and Susceptibility to Essential Hypertension in the Southwest Han Chinese Population.

Authors:  Qian Li; Tangxin Gao; Yuncang Yuan; Yanrui Wu; Qionglin Huang; Fei Xie; Pengzhan Ran; Lijuan Sun; Chunjie Xiao
Journal:  Med Sci Monit       Date:  2017-05-24

3.  Association of genetic polymorphisms of SelS with Type 2 diabetes in a Chinese population.

Authors:  Long Zhao; Ying-Ying Zheng; You Chen; Yi-Tong Ma; Yi-Ning Yang; Xiao-Mei Li; Xiang Ma; Xiang Xie
Journal:  Biosci Rep       Date:  2018-11-28       Impact factor: 3.840

4.  Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang.

Authors:  Yi Luo; Cheng Liu; Tianwang Guan; Yanfang Li; Yanxian Lai; Fang Li; Haiyan Zhao; Tutiguli Maimaiti; Abudurexiti Zeyaweiding
Journal:  Hypertens Res       Date:  2018-12-12       Impact factor: 3.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.